TY - JOUR
T1 - Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience
AU - Lacarrubba, F.
AU - Dini, V.
AU - Dini, Veronica
AU - Napolitano, M.
AU - Venturini, M.
AU - Caposiena Caro, D. R.
AU - Molinelli, E.
AU - Passoni, E.
AU - Monfrecola, G.
AU - Argenziano, Giuseppe
AU - Berti, Emilio
AU - Berti, Emanuele
AU - Bianchi, Luca
AU - Calzavara Pinton, Piergiacomo
AU - Cannavò, Serafinella Patrizia
AU - Costanzo, Antonio
AU - Costanzo, Rosa Maria Alba
AU - Donini, Massimo
AU - Fabbrocini, Gabriella
AU - Fierro, Maria Teresa
AU - Micali, Giuseppe
AU - Offidani, Annamaria
AU - Parodi, Aurora
AU - Patrizi, Annalisa
AU - Pellacani, Giovanni
AU - Peris, Ketty
AU - Pimpinelli, Nicola
AU - Potenza, Concetta
AU - Romanelli, Marco
AU - Romanelli, Margherita
AU - Rongioletti, Franco
AU - Solivetti, Francesco
AU - Solivetti, Francesco Maria
PY - 2019
Y1 - 2019
N2 - Background: Ultrasound (US) is a real-time non-invasive technique that has been demonstrated to support an early diagnosis and a more precise assessment of hidradenitis suppurativa (HS). Objectives: To compare the clinical and US evaluation of a series of HS patients. Methods: 434 HS patients (259 F, 175 M; mean age 33.82 ±13.31 years) observed across 19 Italian dermatology centres [members of the Italian Ultrasound Working Group (IUWG)] were enrolled in a retrospective study. Clinical staging was obtained by the Hidradenitis Suppurativa Physician's Global Assessment score (HS-PGA), while the ultrasonographic staging was determined by the US HS-PGA, based on the same scores as clinical HS-PGA but performed with the aid of US. Results: At the end of the study, the mean clinical and US HS-PGA scores were 2.70 and 2.92, respectively. Direct comparison of clinical and ultrasonographic assessment revealed that a higher proportion of patients was classified as having moderate and very severe disease by US. In particular, 117 patients (26.96%) had a worse classification by US HS-PGA compared to clinical assessment. Conclusion: Our findings confirm that the use of clinical grading only to assess HS severity may underestimate the real disease severity. US examination can be considered an essential non-invasive imaging tool available to dermatologists for a more accurate diagnosis, staging, treatment planning and monitoring of HS and should be included in the pathway to an optimal standard of care of HS.
AB - Background: Ultrasound (US) is a real-time non-invasive technique that has been demonstrated to support an early diagnosis and a more precise assessment of hidradenitis suppurativa (HS). Objectives: To compare the clinical and US evaluation of a series of HS patients. Methods: 434 HS patients (259 F, 175 M; mean age 33.82 ±13.31 years) observed across 19 Italian dermatology centres [members of the Italian Ultrasound Working Group (IUWG)] were enrolled in a retrospective study. Clinical staging was obtained by the Hidradenitis Suppurativa Physician's Global Assessment score (HS-PGA), while the ultrasonographic staging was determined by the US HS-PGA, based on the same scores as clinical HS-PGA but performed with the aid of US. Results: At the end of the study, the mean clinical and US HS-PGA scores were 2.70 and 2.92, respectively. Direct comparison of clinical and ultrasonographic assessment revealed that a higher proportion of patients was classified as having moderate and very severe disease by US. In particular, 117 patients (26.96%) had a worse classification by US HS-PGA compared to clinical assessment. Conclusion: Our findings confirm that the use of clinical grading only to assess HS severity may underestimate the real disease severity. US examination can be considered an essential non-invasive imaging tool available to dermatologists for a more accurate diagnosis, staging, treatment planning and monitoring of HS and should be included in the pathway to an optimal standard of care of HS.
KW - Ultrasound Working Group experience
KW - Ultrasound Working Group experience
UR - http://hdl.handle.net/10807/206171
U2 - 10.1111/jdv.15847
DO - 10.1111/jdv.15847
M3 - Article
SN - 0926-9959
VL - 33
SP - 10
EP - 14
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
ER -